TABLE 3.
Protein | LDL(+) | LDL(−) | Ratio (−)/(+) |
---|---|---|---|
Apolipoprotein E | 42 ± 16 | 217 ± 51a | 5.2 |
Apolipoprotein A-I | 39 ± 27 | 146 ± 32a | 3.8 |
Apolipoprotein C-III | 90 ± 55 | 374 ± 278a | 4.2 |
Apolipoprotein C-I | 76 ± 50 | 74 ± 54 | 1.0 |
Apolipoprotein C-II | 28 ± 34 | 49 ± 49 | 1.8 |
Apolipoprotein A-II | 29 ± 9 | 141 ± 56a | 4.8 |
Apolipoprotein D | 26 ± 15 | 61 ± 24a | 2.4 |
Apolipoprotein F (inhibitor CETP) | 2 ± 3 | 63 ± 26a | 31.5 |
Apolipoprotein J (Clusterin) | 1 ± 1 | 11 ± 5a | 11.0 |
Apolipoprotein(a) | — | 6 ± 2 | — |
Albumin | 5 ± 4 | 11 ± 10 | 2.2 |
Serum amyloid A-4 protein | 15 ± 13 | 32 ± 24 | 2.1 |
Platelet basic protein | 1 ± 1 | — | — |
Five or six experiments were conducted. Values are mean ± SD expressed in arbitrary molar units. CETP, cholesteryl ester transfer protein.
P < 0.05 versus LDL(+) using the Wilcoxon t-test.